1
2
3
4
5
6
de Jong, Lisa Aniek, van Schoonhoven, Alexander Victor, Hofstra, Hinko Stephan, Postma, Maarten Jacobus, van Hoek, Bart
Veröffentlicht in: de Jong , L A , van Schoonhoven , A V , Hofstra , H S , Postma , M J & van Hoek , B 2021 , ' Budget impact of optimizing rifaximin-alpha use for the prevention of recurrent hepatic encephalopathy in The Netherlands ' , Journal of Medical Economics , vol. 24 , no. 1 , pp. 1149-1163 . https://doi.org/10.1080/13696998.2021.1983291;
2021
Veröffentlicht in: de Jong , L A , van Schoonhoven , A V , Hofstra , H S , Postma , M J & van Hoek , B 2021 , ' Budget impact of optimizing rifaximin-alpha use for the prevention of recurrent hepatic encephalopathy in The Netherlands ' , Journal of Medical Economics , vol. 24 , no. 1 , pp. 1149-1163 . https://doi.org/10.1080/13696998.2021.1983291;
2021
7
Wolters, Sharon, Carpay, Johannes A., Pronk, Marja H., Zuurbier, Karin W.M., Driessen, Maurice T., Lyras, Leonidas, Postma, Maarten J.
Veröffentlicht in: Wolters , S , Carpay , J A , Pronk , M H , Zuurbier , K W M , Driessen , M T , Lyras , L & Postma , M J 2024 , ' A Dutch cost-effectiveness analysis of fremanezumab versus best supportive care in patients with chronic migraine and inadequate response to prior preventive therapy ' , BMC NEUROLOGY , vol. 24 , no. 1 , 214 . https://doi.org/10.1186/s12883-024-03697-x;
2024
Veröffentlicht in: Wolters , S , Carpay , J A , Pronk , M H , Zuurbier , K W M , Driessen , M T , Lyras , L & Postma , M J 2024 , ' A Dutch cost-effectiveness analysis of fremanezumab versus best supportive care in patients with chronic migraine and inadequate response to prior preventive therapy ' , BMC NEUROLOGY , vol. 24 , no. 1 , 214 . https://doi.org/10.1186/s12883-024-03697-x;
2024
8
9
10